QuickView for I-SMAD binding (biogroup)

1. microRNA expression in cells resistant to endocrine therapy or in LTED breast cancer cell lines
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. Fibroblasts from Ercc1-knockout embryos cultured under hypoxic or normoxic conditions
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Kidney epithelial HA1E.101 cells with CRISPR targeted gene knockouts

There were no matches for I-SMAD binding

1. Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-depend…
2. A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma